IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
US7608696B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2004 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | May 11, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/25
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This invention encompasses antibodies specific for IBC-1 (Invasive Breast Cancer-1), methods for diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions, methods of identifying and manufacturing therapeutic compounds, and methods of treating patients with invasive and metastatic breast cancer or degenerative neural conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.